AGA Family of Websites: Gastro.org
Search

Help us advance diversity in GI

Please share this opportunity for GI fellows and residents to participate in a unique program at DDW® 2022. The application deadline is Jan. 31.
d3cae88a-3488-4b63-a8cc-3480d2faa87a-pgzhreuax59d24lrfk381rlballvopsorxic4q7u50
d3cae88a-3488-4b63-a8cc-3480d2faa87a-pgzhreuax59d24lrfk381rlballvopsorxic4q7u50

The application period for the AGA Institute Investing in the Future: Advancing Diversity in GI program has been extended to Monday, Jan. 31, 2022. The primary goal of this program is to encourage and provide support to third-year residents and first-year GI fellows from underrepresented backgrounds as they navigate training stages. 

If you know anyone who is eligible for this program, please share this opportunity with them and encourage them to apply. Your help is always appreciated!

Selected applicants will participate in a special agenda at Digestive Disease Week® (DDW) 2022, including daily presentations tailored to physicians and scientists from underrepresented backgrounds, networking with key leaders and industry professionals, and dedicated time to attend other DDW programming.

Eligibility

Participants must be a member of an underrepresented population, as defined by the NIH, who is interested in inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Applicants must meet the following additional criteria:

  • Currently enrolled in an academic institution as a third-year medical resident or first-year GI fellow, and possess an advanced degree, such as MD, PhD, DVM, DO.
  • Must be a U.S. citizen, non-citizen national or individual lawfully admitted for permanent residence at the time of award selection.

Applicants and their training directors will be notified of their application status mid-March 2022.

Help us spread the word

Take advantage of this opportunity to advance diversity in GI and support a young gastroenterologist's career. Please spread the word and share this program with residents and fellows who may be interested.
This program is supported by unrestricted grants from AbbVie, Inc. and Ironwood Pharmaceuticals, Inc.
See what AGA has planned for
Digestive Disease Week®

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.

X